PORTLAND, Ore. -- IBM's medical diagnostics analytics are not exactly a 'cure'
for cancer, but they are aiming to lower the cost of a promising new remedy for
destroying existing tumors. The new technique uses a high-energy particle
accelerator -- a room-sized version of the gigantic accelerators used to unravel
physics -- that directs a proton beam to precisely kill the cancer cells inside
tumors, leaving adjacent tissue untouched. IBM Research (Austin, Texas) is
aiming to reduce the cost of this promising new therapy, using software
analytics running on a Power7 cluster supercomputer.
The stakes are huge. Last year there were over 12 million cancer patients worldwide receiving various therapies, and that number is predicted to increase to 21 million by 2030. Unfortunately, today there are only 10 centers offering proton therapy, however 17 new ones are currently under construction at a cost of over $200 million each. Over $3.4 billion is being invested in current-generation proton accelerators, and smaller, less expensive accelerators are also being designed to make the technique more affordable.
The big bottleneck, however, is the computational workload required to utilize proton therapy.
Today proton therapy requires a long involved preparation process, starting with a magnetic resonance imaging (MRI) or computational tomography (CT) scan to identify the tumor's location, after which a bevy of doctors and technicians spend over a week mapping out exactly how to use a proton beam to destroy it. Unlike traditional radiation therapy, proton beams do not affect human tissue as they pass through it, only releasing their energy at the very end of the path, which must be carefully plotted to end precisely within the tumor.
The stakes are huge. Last year there were over 12 million cancer patients worldwide receiving various therapies, and that number is predicted to increase to 21 million by 2030. Unfortunately, today there are only 10 centers offering proton therapy, however 17 new ones are currently under construction at a cost of over $200 million each. Over $3.4 billion is being invested in current-generation proton accelerators, and smaller, less expensive accelerators are also being designed to make the technique more affordable.
The big bottleneck, however, is the computational workload required to utilize proton therapy.
Today proton therapy requires a long involved preparation process, starting with a magnetic resonance imaging (MRI) or computational tomography (CT) scan to identify the tumor's location, after which a bevy of doctors and technicians spend over a week mapping out exactly how to use a proton beam to destroy it. Unlike traditional radiation therapy, proton beams do not affect human tissue as they pass through it, only releasing their energy at the very end of the path, which must be carefully plotted to end precisely within the tumor.
 |
"The protons are accelerated
to half the speed of light, but do not loose that energy until they hit a
threshold, after which they release burst of kinetic energy," said IBM Research
scientist, Sani Nassif. "Therefore, they can go deep into the body -- almost six
inches deep -- where they create a very dynamic hot spot while not touching
anything between the skin and that point."
Source: http://www.eetimes.com/electronics-news/4414133/IBM-analytics-solving-cancer
Aucun commentaire:
Enregistrer un commentaire